Advanced Filter

Filter by Group

Filter by Market Availability

Did you mean melanoma ii?
Displaying drugs 526 - 550 of 713 in total
Dutogliptin has been investigated for the treatment of Diabetes Mellitus, Type II.
Investigational
Matched Description: … Dutogliptin has been investigated for the treatment of Diabetes Mellitus, Type II. …
Preimplantation factor is under investigation in clinical trial NCT03593460 (Phase II Autoimmune Hepatitis).
Investigational
Matched Description: … Preimplantation factor is under investigation in clinical trial NCT03593460 (Phase II Autoimmune Hepatitis …
Granotapide has been used in trials studying the treatment of Type II Diabetes Mellitus.
Investigational
Matched Description: … Granotapide has been used in trials studying the treatment of Type II Diabetes Mellitus. …
SP1049C is a novel anthracycline chemotherapeutic agent containing doxorubicin and two nonionic pluronic block copolymers. It is designed to overcome drug resistance in a number of cancers. It has successfully completed Phase 1 trials. Phase 2 results are currently under final review. Preliminary data, in its first clinically tested indication,...
Investigational
Experimental
Vet approved
An essential branched-chain aliphatic amino acid found in many proteins. It is an isomer of leucine. It is important in hemoglobin synthesis and regulation of blood sugar and energy levels.
Investigational
Nutraceutical
Matched Mixtures name: … Aminosyn II ... Aminosyn II ... Aminosyn II
Proline is one of the twenty amino acids used in living organisms as the building blocks of proteins. Proline is sometimes called an imino acid, although the IUPAC definition of an imine requires a carbon-nitrogen double bond. Proline is a non-essential amino acid that is synthesized from glutamic acid. It...
Nutraceutical
Matched Mixtures name: … Aminosyn II ... Aminosyn II ... Aminosyn II
Experimental
Investigational
Pegsunercept is used for treating rheumatoid arthritis. Phase II clinical trials were completed in January 2010.
Investigational
Matched Description: … Phase II clinical trials were completed in January 2010. …
Acridine Carboxamide has been used in trials studying the treatment of Lung Cancer and Brain and Central Nervous System Tumors.
Investigational
Matched Categories: … Topoisomerase II Inhibitors …
A synthetic decapeptide, water-soluble Gonadotropin-releasing hormone antagonist. It has reached phase II clinical trials.
Investigational
Matched Description: … It has reached phase II clinical trials. …
Nafithromycin is under investigation in clinical trial NCT02903836 (Phase II Study of Oral Nafithromycin in CABP).
Investigational
Matched Description: … Nafithromycin is under investigation in clinical trial NCT02903836 (Phase II Study of Oral Nafithromycin …
Experimental
Ceralasertib is under investigation in clinical trial NCT03682289 (Phase II Trial of AZD6738 Alone and in Combination With Olaparib).
Investigational
Matched Description: … Ceralasertib is under investigation in clinical trial NCT03682289 (Phase II Trial of AZD6738 Alone and …
Pabinafusp alfa is under investigation in clinical trial NCT03568175 (A Study of JR-141 in Patients With Mucopolysaccharidosis II).
Investigational
Matched Description: … investigation in clinical trial NCT03568175 (A Study of JR-141 in Patients With Mucopolysaccharidosis II
Uliledlimab is under investigation in clinical trial NCT04322006 (A Phase I/II Study of TJ004309 for Advanced Solid Tumor).
Investigational
Matched Description: … Uliledlimab is under investigation in clinical trial NCT04322006 (A Phase I/II Study of TJ004309 for …
An essential amino acid that is required for the production of histamine.
Investigational
Nutraceutical
Matched Mixtures name: … Aminosyn II ... Aminosyn II ... Aminosyn II
Alanine is a non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases immunity, and provides energy for muscle tissue, brain, and the central nervous system.
Nutraceutical
Matched Mixtures name: … Aminosyn II ... Aminosyn II ... Aminosyn II
GPX-100 is an anthracycline anticancer drug that belongs to the family of drugs called antitumor antibiotics.
Investigational
Experimental
Matched Categories: … Corticosteroids, Moderately Potent (Group II) …
An essential amino acid that is physiologically active in the L-form.
Investigational
Nutraceutical
Matched Mixtures name: … Aminosyn II ... Aminosyn II ... Aminosyn II
Amrubicin is a third-generation synthetic anthracycline currently in development for the treatment of small cell lung cancer. Pharmion licensed the rights to Amrubicin in November 2006. In 2002, Amrubicin was approved and launched for sale in Japan based on Phase 2 efficacy data in both SCLC and NSCLC. Since January...
Investigational
Etirinotecan pegol is under investigation in clinical trial NCT01663012 (Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma).
Investigational
Matched Description: … Etirinotecan pegol is under investigation in clinical trial NCT01663012 (Phase II NKTR-102 In Bevacizumab-Resistant …
Matched Categories: … Topoisomerase II Inhibitors …
P54 reduces the inflammation associated with cancer/tumors, Crohn's disease, inflammatory bowel disease, osteoarthritis, and ulcerative colitis. It inhibits the induction of the enzyme NFkB, thereby inhibiting downstream inflammatory genes such as COX II and iNOS.
Investigational
Matched Description: … inhibits the induction of the enzyme NFkB, thereby inhibiting downstream inflammatory genes such as COX II
Displaying drugs 526 - 550 of 713 in total